PAR 3.23% 30.0¢ paradigm biopharmaceuticals limited..

Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study, page-233

  1. 2,123 Posts.
    lightbulb Created with Sketch. 568
    Pity Dungiven can’t say the removal of moving forward with TGA provisional approval would solve a lot for his gnashing of the teeth in this regard.

    that is what has blown out the share price.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
30.0¢
Change
-0.010(3.23%)
Mkt cap ! $104.9M
Open High Low Value Volume
31.0¢ 31.5¢ 29.0¢ $161.3K 527.5K

Buyers (Bids)

No. Vol. Price($)
2 10756 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 62010 3
View Market Depth
Last trade - 16.10pm 15/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.